In RA, it has been suggested that serum ADA activity acts as a biochemical marker in disease diagnosis and determination of disease activity [10], maintaining and promoting an inflammatory state due to the inhibition of the anti-inflammatory role of adenosine. This evidence concerns the gene ADA and rheumatoid arthritis.